For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the arrival of Vyndamax and Attruby represents a true change. These innovative therapies protect the https://attr-cm023675.blogproducer.com/49965079/major-attr-cm-development-tafamidis-and-attruby-give-hope